|
GATAD2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.51077999999139E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.46879999671523E-08 |
| Normal-vs-Stage2 |
1.449590E-01 |
| Normal-vs-Stage3 |
1.943990E-02 |
| Normal-vs-Stage4 |
6.683400E-03 |
| Stage1-vs-Stage2 |
7.463300E-03 |
| Stage1-vs-Stage3 |
2.200900E-03 |
| Stage1-vs-Stage4 |
6.375900E-02 |
| Stage2-vs-Stage3 |
6.385400E-01 |
| Stage2-vs-Stage4 |
3.293600E-01 |
| Stage3-vs-Stage4 |
4.685000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.59339999999242E-05 |
| Normal-vs-AfricanAmerican |
1.75907999999669E-05 |
| Normal-vs-Asian |
1.120210E-02 |
| Caucasian-vs-AfricanAmerican |
1.644150E-02 |
| Caucasian-vs-Asian |
3.371200E-01 |
| AfricanAmerican-vs-Asian |
9.977600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.462150E-03 |
| Normal-vs-Female |
4.86609996741549E-09 |
| Male-vs-Female |
6.10420000000111E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.422500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.52090000005156E-06 |
| Normal-vs-Age(61-80Yrs) |
3.196800E-04 |
| Normal-vs-Age(81-100Yrs) |
3.525200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.935600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.815800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.262600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.523190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.484770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.120000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.19320000003098E-07 |
| Normal-vs-Grade 2 |
6.64039999986876E-07 |
| Normal-vs-Grade 3 |
6.156000E-03 |
| Normal-vs-Grade 4 |
1.080800E-03 |
| Grade 1-vs-Grade 2 |
3.431700E-02 |
| Grade 1-vs-Grade 3 |
8.960100E-04 |
| Grade 1-vs-Grade 4 |
3.715800E-03 |
| Grade 2-vs-Grade 3 |
1.102490E-02 |
| Grade 2-vs-Grade 4 |
3.410000E-01 |
| Grade 3-vs-Grade 4 |
3.420800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62343999999814E-05 |
| Normal-vs-ccB subtype |
4.813900E-04 |
| ccA subtype-vs-ccB subtype |
4.155400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.232600E-04 |
| Normal-vs-N1 |
1.438300E-02 |
| N0-vs-N1 |
5.402200E-01 |
|
|
